NanoTess Inc.
NanoTess Inc is a social enterprise dedicated to providing affordable and accessible nanotechnology innovations for wound care and skin health. Founded by a team with over 40 years of experience in material science, the company focuses on developing cutting-edge, patient-first solutions to improve healing outcomes and reduce healthcare costs. Their flagship product, NanoSALV Catalytic Advanced Wound Care Treatment Matrix, is a Health Canada approved medical device that accelerates wound healing, reduces inflammation, and offers broad-spectrum antimicrobial protection. NanoTess is committed to quality, compassion, resourcefulness, and breaking down barriers to healthcare access.
Industries
Nr. of Employees
small (1-50)
Products
NanoSALV Catalytic Advanced Wound Care Treatment Matrix
A topical amorphous cellulose matrix gel incorporating a composite nanomaterial designed to accelerate wound healing, reduce inflammation, and provide broad-spectrum antimicrobial and anti-biofilm protection while maintaining a moist wound microenvironment.
NanoSALV Catalytic Advanced Wound Care Treatment Matrix
A topical amorphous cellulose matrix gel incorporating a composite nanomaterial designed to accelerate wound healing, reduce inflammation, and provide broad-spectrum antimicrobial and anti-biofilm protection while maintaining a moist wound microenvironment.
Services
Support for healthcare organizations to integrate the topical treatment into care pathways, including access to clinical references, operational resources, and contact-based clinical assistance.
Support for healthcare organizations to integrate the topical treatment into care pathways, including access to clinical references, operational resources, and contact-based clinical assistance.
Expertise Areas
- Wound care and skin health
- Nanomaterials for biomedical applications
- Topical formulation and matrix gels
- Antimicrobial and anti-biofilm technologies
Key Technologies
- Solid-state heterogeneous biocatalysts
- Composite nanomaterials
- Amorphous cellulose matrix gel
- Topical antimicrobial/biofilm protection
News & Updates
Global News highlights how NanoTess is transforming healing with NanoSALV, helping thousands of Canadians heal faster.
NanoSALV Catalytic Advanced Wound Care Treatment Matrix is a Health Canada approved medical device with Licence No.: 108236.
Global News highlights how NanoTess is transforming healing with NanoSALV, helping thousands of Canadians heal faster.
NanoSALV Catalytic Advanced Wound Care Treatment Matrix is a Health Canada approved medical device with Licence No.: 108236.